Abstract
The APOBEC3 (A3) family of cytidine deaminases plays a vital role for innate defense against retroviruses. Lentiviruses such as HIV-1 evolved the Vif protein that triggers A3 protein degradation. There are seven A3 proteins, A3A-A3H, found in humans. All A3 proteins can deaminate cytidines to uridines in single-stranded DNA (ssDNA), generated during viral reverse transcription. A3 proteins have either one or two cytidine deaminase domains (CD). The CDs coordinate a zinc ion, and their amino acid specificity classifies the A3s into A3Z1, A3Z2, and A3Z3. A3 proteins occur as monomers, dimers, and large oligomeric complexes. Studies on the nature of A3 oligomerization, as well as the mode of interaction of A3s with RNA and ssDNA are partially controversial. High-resolution structures of the catalytic CD2 of A3G and A3F as well as of the single CD proteins A3A and A3C have been published recently. The NMR and X-ray crystal structures show globular proteins with six α-helices and five β sheets arranged in a characteristic motif (α1-β1-β2/2′-α2-β3-α3-β4-α4-β5-α5-α6). However, the detailed arrangement and extension of individual structure elements and their relevance for A3 complex formation and activity remains a matter of debate and will be highlighted in this review.
We gratefully acknowledge the support (and training) from the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich-Heine-University of Düsseldorf, and the Entrepreneur Foundation at the Heinrich-Heine-University of Düsseldorf. CM is supported by the Heinz Ansmann Foundation for AIDS Research. We thank Lutz Schmitt and Dieter Willbold for their continuous support.
References
Albin, J.S. and Harris, R.S. (2010). Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert. Rev. Mol. Med 12, e4.10.1017/S1462399409001343Search in Google Scholar PubMed PubMed Central
Albin, J.S., LaRue, R.S., Weaver, J.A., Brown, W.L., Shindo, K., Harjes, E., Matsuo, H., and Harris, R.S. (2010). A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif. J. Biol. Chem. 285, 40785–40792.10.1074/jbc.M110.173161Search in Google Scholar PubMed PubMed Central
Arias, J.F., Koyama, T., Kinomoto, M., and Tokunaga, K. (2012). Retroelements versus APOBEC3 family members: no great escape from the magnificent seven. Front. Microbiol. 3, 275.10.3389/fmicb.2012.00275Search in Google Scholar PubMed PubMed Central
Autore, F., Bergeron, J.R., Malim, M.H., Fraternali, F., and Huthoff, H. (2010). Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations. PLoS One. 5, e11515.10.1371/journal.pone.0011515Search in Google Scholar PubMed PubMed Central
Bennett, R.P., Salter, J.D., Liu, X., Wedekind, J.E., and Smith, H.C. (2008). APOBEC3G subunits self-associate via the C-terminal deaminase domain. J. Biol. Chem. 283, 33329–33336.10.1074/jbc.M803726200Search in Google Scholar PubMed PubMed Central
Bergeron, J.R., Huthoff, H., Veselkov, D.A., Beavil, R.L., Simpson, P.J., Matthews, S.J., Malim, M.H., and Sanderson, M.R. (2010). The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathog. 6, e1000925.10.1371/journal.ppat.1000925Search in Google Scholar PubMed PubMed Central
Bohn, M.F., Shandilya, S.M., Albin, J.S., Kouno, T., Anderson, B.D., McDougle, R.M., Carpenter, M.A., Rathore, A., Evans, L., Davis, A.N., et al. (2013). Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain. Structure 21, 1042–1050.10.1016/j.str.2013.04.010Search in Google Scholar PubMed PubMed Central
Bulliard, Y., Turelli, P., Rohrig, U.F., Zoete, V., Mangeat, B., Michielin, O., and Trono, D. (2009). Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition. J. Virol. 83, 12611–12621.10.1128/JVI.01491-09Search in Google Scholar PubMed PubMed Central
Burnett, A. and Spearman, P. (2007). APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J. Virol. 81, 5000–5013.10.1128/JVI.02237-06Search in Google Scholar PubMed PubMed Central
Burns, M.B., Lackey, L., Carpenter, M.A., Rathore, A., Land, A.M., Leonard, B., Refsland, E.W., Kotandeniya, D., Tretyakova, N., Nikas, J.B., et al. (2013). APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366–370.10.1038/nature11881Search in Google Scholar PubMed PubMed Central
Byeon, I.J., Ahn, J., Mitra, M., Byeon, C.H., Hercik, K., Hritz, J., Charlton, L.M., Levin, J.G., and Gronenborn, A.M. (2013). NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity. Nat. Commun. 4, 1890.10.1038/ncomms2883Search in Google Scholar PubMed PubMed Central
Chareza, S., Slavkovic, L.D., Liu, Y., Rathe, A.M., Münk, C., Zabogli, E., Pistello, M., and Löchelt, M. (2012). Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: different ways to counteract host-encoded restriction. Virology 424, 138–146.10.1016/j.virol.2011.12.017Search in Google Scholar PubMed
Chelico, L., Pham, P., Calabrese, P., and Goodman, M.F. (2006). APOBEC3G DNA deaminase acts processively 3′→5′ on single-stranded DNA. Nat. Struct. Mol. Biol 13, 392–399.10.1038/nsmb1086Search in Google Scholar PubMed
Chelico, L., Sacho, E.J., Erie, D.A., and Goodman, M.F. (2008). A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV. J. Biol. Chem. 283, 13780–13791.10.1074/jbc.M801004200Search in Google Scholar PubMed PubMed Central
Chelico, L., Prochnow, C., Erie, D.A., Chen, X.S., and Goodman, M.F. (2010). Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G. J. Biol. Chem. 285, 16195–16205.10.1074/jbc.M110.107987Search in Google Scholar PubMed PubMed Central
Chen, K.M., Harjes, E., Gross, P.J., Fahmy, A., Lu, Y., Shindo, K., Harris, R.S., and Matsuo, H. (2008). Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 452, 116–119.10.1038/nature06638Search in Google Scholar PubMed
Chiu, Y.L., Witkowska, H.E., Hall, S.C., Santiago, M., Soros, V.B., Esnault, C., Heidmann, T., and Greene, W.C. (2006). High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl. Acad. Sci. USA 103, 15588–15593.10.1073/pnas.0604524103Search in Google Scholar PubMed PubMed Central
Conticello, S.G. (2008). The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9, 229.10.1186/gb-2008-9-6-229Search in Google Scholar PubMed PubMed Central
Derse, D., Hill, S.A., Princler, G., Lloyd, P., and Heidecker, G. (2007). Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Proc. Natl. Acad. Sci. USA 104, 2915–2920.10.1073/pnas.0609444104Search in Google Scholar PubMed PubMed Central
Feng, Y. and Chelico, L. (2011). Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain. J. Biol. Chem. 286, 11415–11426.10.1074/jbc.M110.199604Search in Google Scholar PubMed PubMed Central
Friew, Y.N., Boyko, V., Hu, W.S., and Pathak, V.K. (2009). Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA. Retrovirology 6, 56.10.1186/1742-4690-6-56Search in Google Scholar PubMed PubMed Central
Furukawa, A., Nagata, T., Matsugami, A., Habu, Y., Sugiyama, R., Hayashi, F., Kobayashi, N., Yokoyama, S., Takaku, H., and Katahira, M. (2009). Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G. EMBO J. 28, 440–451.10.1038/emboj.2008.290Search in Google Scholar PubMed PubMed Central
Gallois-Montbrun, S., Kramer, B., Swanson, C.M., Byers, H., Lynham, S., Ward, M., and Malim, M.H. (2007). Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol. 81, 2165–2178.10.1128/JVI.02287-06Search in Google Scholar PubMed PubMed Central
Gallois-Montbrun, S., Holmes, R.K., Swanson, C.M., Fernandez-Ocana, M., Byers, H.L., Ward, M.A., and Malim, M.H. (2008). Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J. Virol. 82, 5636–5642.10.1128/JVI.00287-08Search in Google Scholar PubMed PubMed Central
Hache, G., Liddament, M.T., and Harris, R.S. (2005). The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain. J. Biol. Chem. 280, 10920–10924.10.1074/jbc.M500382200Search in Google Scholar PubMed
Harjes, E., Gross, P.J., Chen, K.M., Lu, Y., Shindo, K., Nowarski, R., Gross, J.D., Kotler, M., Harris, R.S., and Matsuo, H. (2009). An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model. J. Mol. Biol 389, 819–832.10.1016/j.jmb.2009.04.031Search in Google Scholar PubMed PubMed Central
Harris, R.S., Petersen-Mahrt, S.K., and Neuberger, M.S. (2002). RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247–1253.10.1016/S1097-2765(02)00742-6Search in Google Scholar PubMed
Holden, L.G., Prochnow, C., Chang, Y.P., Bransteitter, R., Chelico, L., Sen, U., Stevens, R.C., Goodman, M.F., and Chen, X.S. (2008). Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature 456, 121–124.10.1038/nature07357Search in Google Scholar PubMed PubMed Central
Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F., and Malim, M.H. (2009). RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog. 5, e1000330.10.1371/journal.ppat.1000330Search in Google Scholar PubMed PubMed Central
Iwatani, Y., Takeuchi, H., Strebel, K., and Levin, J.G. (2006). Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. J. Virol. 80, 5992–6002.10.1128/JVI.02680-05Search in Google Scholar PubMed PubMed Central
Jager, S., Kim, D.Y., Hultquist, J.F., Shindo, K., LaRue, R.S., Kwon, E., Li, M., Anderson, B.D., Yen, L., Stanley, D., et al. (2012). Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature 481, 371–375.10.1038/nature10693Search in Google Scholar PubMed PubMed Central
Jaguva Vasudevan, A.A., Perkovic, M., Bulliard, Y., Cichutek, K., Trono, D., Haussinger, D., and Munk, C. (2013). Prototype foamy virus bet impairs the dimerization and cytosolic solubility of human APOBEC3G. J. Virol. 2013 Jun 12. [Epub ahead of print].10.1128/JVI.03385-12Search in Google Scholar PubMed PubMed Central
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., and Navaratnam, N. (2002). An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285–296.10.1006/geno.2002.6718Search in Google Scholar PubMed
Kitamura, S., Ode, H., Nakashima, M., Imahashi, M., Naganawa, Y., Kurosawa, T., Yokomaku, Y., Yamane, T., Watanabe, N., Suzuki, A., et al. (2012). The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. Nat. Struct. Mol. Biol 19, 1005–1010.10.1038/nsmb.2378Search in Google Scholar PubMed
Kolokithas, A., Rosenke, K., Malik, F., Hendrick, D., Swanson, L., Santiago, M.L., Portis, J.L., Hasenkrug, K.J., and Evans, L.H. (2010). The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3. J. Virol. 84, 10933–10936.10.1128/JVI.01023-10Search in Google Scholar PubMed PubMed Central
Kozak, S.L., Marin, M., Rose, K.M., Bystrom, C., and Kabat, D. (2006). The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J. Biol. Chem. 281, 29105–29119.10.1074/jbc.M601901200Search in Google Scholar PubMed
Kreisberg, J.F., Yonemoto, W., and Greene, W.C. (2006). Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203, 865–870.10.1084/jem.20051856Search in Google Scholar PubMed PubMed Central
Krissinel, E. and Henrick, K. (2007). Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797.10.1016/j.jmb.2007.05.022Search in Google Scholar PubMed
LaRue, R.S., Jonsson, S.R., Silverstein, K.A., Lajoie, M., Bertrand, D., El-Mabrouk, N., Hotzel, I., Andresdottir, V., Smith, T.P., and Harris, R.S. (2008). The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. Mol. Biol. 9, 104.10.1186/1471-2199-9-104Search in Google Scholar PubMed PubMed Central
LaRue, R.S., Andresdottir, V., Blanchard, Y., Conticello, S.G., Derse, D., Emerman, M., Greene, W.C., Jonsson, S.R., Landau, N.R., Löchelt, M., et al. (2009). Guidelines for naming nonprimate APOBEC3 genes and proteins. J. Virol. 83, 494–497.10.1128/JVI.01976-08Search in Google Scholar PubMed PubMed Central
Li, M., Shandilya, S.M., Carpenter, M.A., Rathore, A., Brown, W.L., Perkins, A.L., Harki, D.A., Solberg, J., Hook, D.J., Pandey, K.K., et al. (2012). First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G. ACS Chem. Biol. 7, 506–517.10.1021/cb200440ySearch in Google Scholar PubMed PubMed Central
Löchelt, M., Romen, F., Bastone, P., Muckenfuss, H., Kirchner, N., Kim, Y.B., Truyen, U., Rosler, U., Battenberg, M., Saib, A., et al. (2005). The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. USA 102, 7982–7987.10.1073/pnas.0501445102Search in Google Scholar PubMed PubMed Central
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., and Landau, N.R. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21–31.10.1016/S0092-8674(03)00515-4Search in Google Scholar
Marin, M., Rose, K.M., Kozak, S.L., and Kabat, D. (2003). HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9, 1398–1403.10.1038/nm946Search in Google Scholar PubMed
Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M., and Gabuzda, D. (2004). Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18, 2861–2866.10.1101/gad.1249904Search in Google Scholar PubMed PubMed Central
Münk, C., Beck, T., Zielonka, J., Hotz-Wagenblatt, A., Chareza, S., Battenberg, M., Thielebein, J., Cichutek, K., Bravo, I.G., O’Brien, S.J., et al. (2008). Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 9, R48.10.1186/gb-2008-9-3-r48Search in Google Scholar PubMed PubMed Central
Münk, C., Jensen, B.E., Zielonka, J., Häussinger, D., and Kamp, C. (2012a). Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein. Viruses 4, 3132–3161.10.3390/v4113132Search in Google Scholar PubMed PubMed Central
Münk, C., Willemsen, A., and Bravo, I.G. (2012b). An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals. BMC. Evol. Biol 12, 71.10.1186/1471-2148-12-71Search in Google Scholar PubMed PubMed Central
Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., and Landau, N.R. (2005). Complementary function of the two catalytic domains of APOBEC3G. Virology 333, 374–386.10.1016/j.virol.2005.01.011Search in Google Scholar PubMed
Niewiadomska, A.M., Tian, C., Tan, L., Wang, T., Sarkis, P.T., and Yu, X.F. (2007). Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J. Virol. 81, 9577–9583.10.1128/JVI.02800-06Search in Google Scholar PubMed PubMed Central
Nik-Zainal, S., Alexandrov, L.B., Wedge, D.C., Van, L.P., Greenman, C.D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L.A., et al. (2012). Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993.10.1016/j.cell.2012.04.024Search in Google Scholar PubMed PubMed Central
Nowarski, R. and Kotler, M. (2013). APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. Cancer Res. 73, 3494–3498.10.1158/0008-5472.CAN-13-0728Search in Google Scholar PubMed PubMed Central
Nowarski, R., Britan-Rosich, E., Shiloach, T., and Kotler, M. (2008). Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nat. Struct. Mol. Biol. 15, 1059–1066.10.1038/nsmb.1495Search in Google Scholar PubMed
Ooms, M., Krikoni, A., Kress, A.K., Simon, V., and Münk, C. (2012). APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1. J. Virol. 86, 6097–6108.10.1128/JVI.06570-11Search in Google Scholar PubMed PubMed Central
Perkovic, M., Schmidt, S., Marino, D., Russell, R.A., Stauch, B., Hofmann, H., Kopietz, F., Kloke, B.P., Zielonka, J., Strover, H., et al. (2009). Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J. Biol. Chem. 284, 5819–5826.10.1074/jbc.M808853200Search in Google Scholar PubMed PubMed Central
Prochnow, C., Bransteitter, R., Klein, M.G., Goodman, M.F., and Chen, X.S. (2007). The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 445, 447–451.10.1038/nature05492Search in Google Scholar PubMed
Rausch, J.W., Chelico, L., Goodman, M.F., and Le Grice, S.F. (2009). Dissecting APOBEC3G substrate specificity by nucleoside analog interference. J. Biol. Chem. 284, 7047–7058.10.1074/jbc.M807258200Search in Google Scholar PubMed PubMed Central
Roberts, S.A., Sterling, J., Thompson, C., Harris, S., Mav, D., Shah, R., Klimczak, L.J., Kryukov, G.V., Malc, E., Mieczkowski, P.A., et al. (2012). Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424–435.10.1016/j.molcel.2012.03.030Search in Google Scholar PubMed PubMed Central
Russell, R.A., Wiegand, H.L., Moore, M.D., Schafer, A., McClure, M.O., and Cullen, B.R. (2005). Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 79, 8724–8731.10.1128/JVI.79.14.8724-8731.2005Search in Google Scholar PubMed PubMed Central
Salter, J.D., Krucinska, J., Raina, J., Smith, H.C., and Wedekind, J.E. (2009). A hydrodynamic analysis of APOBEC3G reveals a monomer-dimer-tetramer self-association that has implications for anti-HIV function. Biochemistry 48, 10685–10687.10.1021/bi901642cSearch in Google Scholar PubMed PubMed Central
Schumacher, A.J., Hache, G., MacDuff, D.A., Brown, W.L., and Harris, R.S. (2008). The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 82, 2652–2660.10.1128/JVI.02391-07Search in Google Scholar PubMed PubMed Central
Shandilya, S.M., Nalam, M.N., Nalivaika, E.A., Gross, P.J., Valesano, J.C., Shindo, K., Li, M., Munson, M., Royer, W.E., Harjes, E., et al. (2010). Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces. Structure 18, 28–38.10.1016/j.str.2009.10.016Search in Google Scholar PubMed PubMed Central
Sheehy, A.M., Gaddis, N.C., Choi, J.D., and Malim, M.H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646–650.10.1038/nature00939Search in Google Scholar PubMed
Sheehy, A.M., Gaddis, N.C., and Malim, M.H. (2003). The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404–1407.10.1038/nm945Search in Google Scholar PubMed
Shlyakhtenko, L.S., Lushnikov, A.Y., Li, M., Lackey, L., Harris, R.S., and Lyubchenko, Y.L. (2011). Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3G. J. Biol. Chem. 286, 3387–3395.10.1074/jbc.M110.195685Search in Google Scholar PubMed PubMed Central
Shlyakhtenko, L.S., Lushnikov, A.Y., Miyagi, A., Li, M., Harris, R.S., and Lyubchenko, Y.L. (2012). Nanoscale structure and dynamics of ABOBEC3G complexes with single-stranded DNA. Biochemistry 51, 6432–6440.10.1021/bi300733dSearch in Google Scholar PubMed PubMed Central
Smith, J.L. and Pathak, V.K. (2010). Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif. J. Virol. 84, 12599–12608.10.1128/JVI.01437-10Search in Google Scholar PubMed PubMed Central
Song, C., Sutton, L., Johnson, M.E., D’Aquila, R.T., and Donahue, J.P. (2012). Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction. J. Biol. Chem. 287, 16965–16974.10.1074/jbc.M111.310839Search in Google Scholar PubMed PubMed Central
Soros, V.B., Yonemoto, W., and Greene, W.C. (2007). Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS. Pathog. 3, e15.10.1371/journal.ppat.0030015Search in Google Scholar PubMed PubMed Central
Stauch, B., Hofmann, H., Perkovic, M., Weisel, M., Kopietz, F., Cichutek, K., Münk, C., and Schneider, G. (2009). Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation. Proc. Natl. Acad. Sci. USA 106, 12079–12084.10.1073/pnas.0900979106Search in Google Scholar PubMed PubMed Central
Stavrou, S., Nitta, T., Kotla, S., Ha, D., Nagashima, K., Rein, A.R., Fan, H., and Ross, S.R. (2013). Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex. Proc. Natl. Acad. Sci. USA 110, 9078–9083. doi: 10.1073/pnas.1217399110. [Epub 2013 May 13].10.1073/pnas.1217399110Search in Google Scholar PubMed PubMed Central
Strebel, K. and Khan, M.A. (2008). APOBEC3G encapsidation into HIV-1 virions: which RNA is it? Retrovirology 5, 55.10.1186/1742-4690-5-55Search in Google Scholar PubMed PubMed Central
Taylor, B.J., Nik-Zainal, S., Wu, Y.L., Stebbings, L.A., Raine, K., Campbell, P.J., Rada, C., Stratton, M.R., and Neuberger, M.S. (2013). DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2, e00534.10.7554/eLife.00534.017Search in Google Scholar
Teh, A.H., Kimura, M., Yamamoto, M., Tanaka, N., Yamaguchi, I., and Kumasaka, T. (2006). The 1.48 A resolution crystal structure of the homotetrameric cytidine deaminase from mouse. Biochemistry 45, 7825–7833.10.1021/bi060345fSearch in Google Scholar PubMed
Wang, T., Zhang, W., Tian, C., Liu, B., Yu, Y., Ding, L., Spearman, P., and Yu, X.F. (2008). Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C. Virology 377, 71–79.10.1016/j.virol.2008.04.012Search in Google Scholar PubMed PubMed Central
Wedekind, J.E., Gillilan, R., Janda, A., Krucinska, J., Salter, J.D., Bennett, R.P., Raina, J., and Smith, H.C. (2006). Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits. J. Biol. Chem. 281, 38122–38126.10.1074/jbc.C600253200Search in Google Scholar PubMed PubMed Central
Wissing, S., Galloway, N.L., and Greene, W.C. (2010). HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors. Mol. Aspects Med. 31, 383–397.10.1016/j.mam.2010.06.001Search in Google Scholar PubMed PubMed Central
Xiang, S., Short, S.A., Wolfenden, R., and Carter, C.W., Jr. (1997). The structure of the cytidine deaminase-product complex provides evidence for efficient proton transfer and ground-state destabilization. Biochemistry 36, 4768–4774.10.1021/bi963091eSearch in Google Scholar PubMed
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X.F. (2003). Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056–1060.10.1126/science.1089591Search in Google Scholar PubMed
Yu, Y., Xiao, Z., Ehrlich, E.S., Yu, X., and Yu, X.F. (2004). Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18, 2867–2872.10.1101/gad.1250204Search in Google Scholar PubMed PubMed Central
Zhang, K.L., Mangeat, B., Ortiz, M., Zoete, V., Trono, D., Telenti, A., and Michielin, O. (2007). Model structure of human APOBEC3G. PLoS One. 2, e378.10.1371/journal.pone.0000378Search in Google Scholar PubMed PubMed Central
Zhang, W., Du, J., Evans, S.L., Yu, Y., and Yu, X.F. (2012). T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481, 376–379.10.1038/nature10718Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston